Inspire Medical reaffirms updated 2025 guidance

2 hours ago 1
Sleep Apnea

matdesign24/iStock via Getty Images

  • Inspire Medical Systems (NYSE:INSP) is reaffirming updated 2025 financial guidance it made earlier this month following its Q2 results.
  • At that time, the maker of a sleep apnea treatment implant significantly cut its revenue and EPS expectations citing slower than

Recommended For You

More Trending News

Read Entire Article